Medicare Part D and Advantage Costs Decrease in 2025
Medicare beneficiaries will pay less in 2025 for Medicare Part D prescription and Advantage plan premiums.
Medicare Part D prescription drug coverage and Medicare Advantage participants will likely pay less than last year for their prescription drug coverage and plan costs. Medicare beneficiaries will see decreases in Medicare Part D and Medicare Advantage plan premiums in 2025. This is great news for budget-conscious seniors who are on track to receive the lowest Social Security COLA increase in four years.
Lower average total Medicare Part D premiums in 2025
In 2025, Medicare beneficiaries will have access to an average of 15 stand-alone Part D plans per region, according to the Centers for Medicare & Medicaid Services (CMS). When comparing 2025 Part D formularies to 2024, the CMS found no significant decreases in formulary inclusion or changes to the tier placement of drugs.
The average total Part D beneficiary premium is projected to decrease by $7.45 in 2025, from $53.95 in 2024 to $46.50 in 2025. The average stand-alone Part D plan total premium is projected to decrease from $41.63 in 2024 to $40.00 in 2025, a decrease of $1.63.
Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
Average Medicare Advantage premiums are expected to decrease
The CMS also announced that average premiums, benefits and plan choices for Medicare Advantage and the Medicare Part D prescription drug program are expected to remain stable in 2025.
According to the CMS, approximately 60% of Medicare Advantage enrollees in their current plan will have a zero-dollar premium in 2025.
The average monthly plan premium for all Medicare Advantage (MA) plans, which includes MA plans with prescription drug coverage, is expected to decrease by $1.23 from $18.23 in 2024 to $17.00 in 2025. The CMS says that approximately 83% of enrollees will have the same or lower premium in 2025 if they continue in the same plan.
The average MA plan with prescription drug coverage Part D total premium is projected to decrease from $15.56 in 2024 to $13.50 in 2025 (a decrease of $2.06).
Other changes coming to Medicare Part D in 2025:
1. New $2,000 annual cap on out-of-pocket prescription costs
Beginning in 2025, people with Part D plans won’t have to pay more than $2,000 in out-of-pocket costs, thanks to a provision in the Inflation Reduction Act of 2022. The $2,000 cap will be indexed to the growth in per capita Part D costs, so it may rise each year after 2025.
This new rule applies only to medications covered by your Part D plan and does not apply to out-of-pocket spending on Medicare Part B drugs. Part B drugs are usually vaccinations, injections a doctor administers, and some outpatient prescription drugs.
2. Option to spread their prescription drug costs throughout the year.
Part D enrollees will also have the option of spreading out their out-of-pocket costs over the year rather than face high out-of-pocket costs in any given month. Part D enrollees who select this payment option will pay $0 to the pharmacy for covered Part D drugs, and Part D plan sponsors will then bill program participants monthly for any cost sharing they incur while in the program.
3. Supplemental Part D benefits count towards individual out-of-pocket costs
People with Medicare enrolled in a Part D plan that offers enhanced supplemental benefits will have the added advantage of these supplemental benefits counting towards their out-of-pocket costs, resulting in their reaching the $2,000 cap for 2025 sooner.
For instance, drugs that are excluded from the definition of Part D drug, even in cases where the plan chooses to cover them as a supplemental benefit, such as drugs for hair growth.
Related Content
Get Kiplinger Today newsletter — free
Profit and prosper with the best of Kiplinger's advice on investing, taxes, retirement, personal finance and much more. Delivered daily. Enter your email in the box and click Sign Me Up.
Donna joined Kiplinger as a personal finance writer in 2023. She spent more than a decade as the contributing editor of J.K.Lasser's Your Income Tax Guide and edited state specific legal treatises at ALM Media. She has shared her expertise as a guest on Bloomberg, CNN, Fox, NPR, CNBC and many other media outlets around the nation.
-
Stock Market Today: The Dow Leads an Up Day for Stocks
Boeing, American Express and Nike were the best Dow stocks to close out the week.
By Karee Venema Published
-
Black Friday Deals: Are They Still Worth It in 2024?
Is Black Friday still the best day for deals? We share top tips for smart holiday shopping.
By Jacob Wolinsky Published